In later stages TGFβ1 acts as a tumor promoter by modulating genomic instability, angiogenesis, lymphangiogenesis, immune suppression, immune evasion, epithelial-mesenchymal transition, endothelial-mesenchymal transition, and cell motility [1, 5, 14, 17, 21, 23]. This evidence concerns the gene TGFB1 and neoplasm.